Patient Care Center

Author name: david

Immix Biopharma Announces 100% Overall Response Rate (n=10); 23.7 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2023

Immix Biopharma Announces 100% Overall Response Rate (n=10); 23.7 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2023 Immix Biopharma, Inc. (Nasdaq:IMMX) 100% (10/10) overall response rate (ORR) and 70% (7/10) complete response (CR) rate observed in standard of care (Dara-CyBorD) relapsed/refractory AL Amyloidosis patients with median 6 …

Immix Biopharma Announces 100% Overall Response Rate (n=10); 23.7 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2023 Read More »

A comparison of multiple myeloma and amyloidosis

Multiple myeloma is an uncommon cancer affecting plasma cells in the bone marrow. Tumors in the bones and other organs can cause the cells to grow out of control. A complication of this cancer is amyloidosis, and both conditions share some similarities. The American Cancer Society estimates that approximately 34,740 peopleTrusted Source will receive a diagnosis of …

A comparison of multiple myeloma and amyloidosis Read More »

Congo red stain: The gold standard for diagnosing amyloidosis

The gold standard for diagnosis of amyloid is the Congo red stain. All forms of amyloid exhibit affinity for Congo red and give off an apple-green birefringence under polarized light. It is one of the characteristics that distinguish amyloid from other fibrils.   Abstract Amyloidosis is a rare group of diseases characterized by deposition of …

Congo red stain: The gold standard for diagnosing amyloidosis Read More »

Clinical Trials Information for Patients and Caregivers

Clinical trials are research studies that involve people. Understanding what they are can help you decide if a clinical trial might be an option for you. Or maybe you have a friend or family member with cancer and are wondering if a clinical trial is right for them. We’ve provided basic information about clinical trials …

Clinical Trials Information for Patients and Caregivers Read More »

Scroll to Top